Quality of life in goserelin-treated versus cyclophosphamide + methotrexate + fluorouracil-treated premenopausal and perimenopausal patients with node-positive, early breast cancer: the Zoladex Early Breast Cancer Research Association Trialists Grou (Q44650477)
Jump to navigation
Jump to search
scientific article published on 10 November 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Quality of life in goserelin-treated versus cyclophosphamide + methotrexate + fluorouracil-treated premenopausal and perimenopausal patients with node-positive, early breast cancer: the Zoladex Early Breast Cancer Research Association Trialists Grou |
scientific article published on 10 November 2003 |
Statements
1 reference
Quality of life in goserelin-treated versus cyclophosphamide + methotrexate + fluorouracil-treated premenopausal and perimenopausal patients with node-positive, early breast cancer: the Zoladex Early Breast Cancer Research Association Trialists Grou (English)
1 reference
H de Haes
1 reference
M Olschewski
1 reference
M Kaufmann
1 reference
M Schumacher
1 reference
W Jonat
1 reference
W Sauerbrei
1 reference
Zoladex Early Breast Cancer Research Association Trialists Group
1 reference
10 November 2003
1 reference
1 reference
21
1 reference
24
1 reference
4510-4516
1 reference
Identifiers
1 reference
1 reference